Return to homepagePandemic Pact

Antiviral drug discovery using an interdisciplinary approach

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA481187

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2026
    2030

  • Known Financial Commitments (USD)

    $1,993,859.54

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    Griffith University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The most recent pandemic, COVID-19, highlighted how under prepared we are against emerging and reemerging viruses. The control of such viruses demands both novel drug discovery and vaccine development programs. This investigator award tackles clinically-significant viruses that have major health burden, in the context of morbidity, mortality and economic impact. The major outcome of this award will be the delivery of novel antiviral drug candidates that will reduce this health burden.